Previous Article | Next Article ![]()
Mol Cell Biol, May 1998, p. 3089-3100, Vol. 18, No. 5
Department of Biology, University of
California, San Diego, La Jolla, California
920931;
Gene Expression Lab, The Salk
Institute for Biological Studies, La Jolla, California
920372;
Departments of Cancer Biology
and Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio
441953; and
Clinical Research
Division, Fred Hutchinson Cancer Research Center, Seattle,
Washington 981094
Received 26 September 1997/Returned for modification 18 November
1997/Accepted 6 February 1998
Amplification of genes involved in signal transduction and cell
cycle control occurs in a significant fraction of human cancers. Loss
of p53 function has been proposed to enable cells with gene amplification to arise spontaneously during growth in vitro. However, this conclusion derives from studies employing the UMP synthesis inhibitor N-phosphonacetyl-L-aspartate (PALA),
which, in addition to selecting for cells containing extra copies of
the CAD locus, enables p53-deficient cells to enter S phase and acquire
the DNA breaks that initiate the amplification process. Thus, it has
not been possible to determine if gene amplification occurs
spontaneously or results from the inductive effects of the selective
agent. The studies reported here assess whether p53 deficiency leads to
spontaneous genetic instability by comparing cell cycle responses and
amplification frequencies of the human fibrosarcoma cell line HT1080
when treated with PALA or with methotrexate, an antifolate that, under
the conditions used, should not generate DNA breaks. p53-deficient
HT1080 cells generated PALA-resistant variants containing amplified CAD
genes at a frequency of >10
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Gene Amplification in a p53-Deficient Cell Line Requires Cell
Cycle Progression under Conditions That Generate DNA Breakage

5. By contrast, methotrexate
selection did not result in resistant cells at a detectable frequency
(<10
9). However, growth of HT1080 cells under conditions
that induced DNA breakage prior to selection generated
methotrexate-resistant clones containing amplified dihydrofolate
reductase sequences at a high frequency. These data demonstrate that,
under standard growth conditions, p53 loss is not sufficient to enable
cells to produce the DNA breaks that initiate amplification. We propose that p53-deficient cells must proceed through S phase under conditions that induce DNA breakage for genetic instability to occur.
*
Corresponding author. Mailing address: Gene Expression
Lab, The Salk Institute for Biological Studies, La Jolla, CA 92037. Phone: (619) 453-4100. Fax: (619) 457-2762. E-mail:
wahl{at}salk.edu.
Present address. Fred Hutchinson Cancer Research Center, Seattle WA
98104.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|